BusinessMedical Marijuana, Inc.’s HempMeds® México Offers Details for Importation of RSHO-X When Purchased in the U.S.By Nasdaq OMXFeb 24, 2016, 2:00 PM UTC
BusinessMedical Marijuana, Inc.’s Zero-THC Cannabidiol (CBD) Hemp Oil, RSHO-X™ From HempMeds®, Featured at Southwest Cannabis Conference in Fort Worth, TXBy Nasdaq OMXFeb 22, 2016, 2:00 PM UTC
BusinessKannalife Sciences Announces Publication of “Discovery of KLS-13019, a Cannabidiol-Derived Neuroprotective Agent, With Improved Potency, Safety and Permeability”By Nasdaq OMXFeb 16, 2016, 4:16 PM UTC
BusinessKannalife Sciences Announces Publication of “Discovery of KLS-13019, a Cannabidiol-Derived Neuroprotective Agent, With Improved Potency, Safety and Permeability”By Nasdaq OMXFeb 16, 2016, 4:16 PM UTC
BusinessMedical Marijuana, Inc.'s RSHO-X Garners FOX 5, Other Global News Coverage After News of Historic Import Permits for Mexican FamiliesBy Nasdaq OMXFeb 12, 2016, 2:00 PM UTC
BusinessMedical Marijuana, Inc.'s CEO on Union Tribune Radio Discussing International Cannabis Law Changes, US Cannabis Exports: RSHO and RSHO-X Cannabidiol (CBD) ProductsBy Nasdaq OMXFeb 11, 2016, 2:00 PM UTC
BusinessMedical Marijuana, Inc.'s HempMeds® México Ships RSHO-X, First-Ever Federally Approved Cannabidiol (CBD) Product February 8By Nasdaq OMXFeb 5, 2016, 2:00 PM UTC
BusinessMedical Marijuana, Inc. Featured by Reuters: Mexico Government Grants Import of RSHO-X, Market Estimated $1-2 Billion for CBD Hemp Oil Over 10 YearsBy Nasdaq OMXFeb 4, 2016, 2:00 PM UTC
